Overview

Study to Evaluate the Effect of GWP42003 on Liver Fat Levels in Participants With Fatty Liver Disease

Status:
Completed
Trial end date:
2012-07-13
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of GWP42003 on liver triglyceride (liver fat) in participants with fatty liver disease (FLD).
Phase:
Phase 2
Details
Lead Sponsor:
GW Research Ltd
Treatments:
Cannabidiol